Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of polypeptide modified nano particle to preparation of drugs for treating acute lung injury

A technology for acute lung injury and polypeptide modification, which is applied in the field of biomedicine to achieve the effects of facilitating in vivo tracking, promoting lung injury repair, and significant curative effect

Active Publication Date: 2017-06-13
SHANGHAI FIRST PEOPLES HOSPITAL
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] There are no related reports on the application of peptide-modified nanoparticles in the treatment of acute lung injury

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of polypeptide modified nano particle to preparation of drugs for treating acute lung injury
  • Application of polypeptide modified nano particle to preparation of drugs for treating acute lung injury
  • Application of polypeptide modified nano particle to preparation of drugs for treating acute lung injury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The preparation of embodiment 1 P12

[0019] The synthesis of gold nanoparticles is to adopt sodium citrate to reduce the chloroauric acid method, and the specific operation method is as follows: 6.45mL chloroauric acid (10.5mg / mL) is added into an Erlenmeyer flask filled with 200mL MiliQ water (18.2MΩ), and heated After heating to boiling on a stirring platform, 2 mL of sodium citrate (10%) was added quickly, and heating and stirring were continued for 15 minutes, then stirred and cooled to room temperature. Peptide (Pep 12: CLPFFD (SEQ ID NO: 1), purity>95%) powder was dissolved in water to prepare a peptide solution (1 mM). Mix the peptide and gold nanoparticle solution at a volume ratio of 1:10, and let stand overnight. Use a 220nm syringe filter head to filter the polypeptide gold nanoparticle suspension, then centrifuge (15000rpm, 30min), wash with PBS three times, and re-concentrate to 1mM for use.

[0020] The prepared polypeptide-modified nanoparticles are co...

Embodiment 2

[0021] Example 2 In vitro test proves that P12 can prevent neutrophils from migrating

[0022] 1. Experimental method

[0023] Take 20ml of human peripheral venous blood, inject it into a heparin anticoagulant tube, and shake it gently. Peripheral blood mononuclear cells were separated by Ficoll density gradient centrifugation. Take out the bottom layer containing erythrocytes, mix it with the same volume of 3% dextran, shake gently, let it settle naturally at room temperature for 1 hour, take the "supernatant part" after Dextran precipitation, centrifuge at 150g for 8 minutes, and resuspend in 0.2% Dextran In NaCl, add an equal volume of 1.6% NaCl after 1 minute, centrifuge at 150g for 8 minutes to remove red blood cells to obtain neutrophils, suspend them in PBS and count them, add CFSE (5 μM), and place the cells at 37 degrees for 30 minutes After centrifugation, wash twice with PBS containing 2% FBS, and suspend it in RPMI1640 medium (containing 10% fetal bovine serum, 5...

Embodiment 3

[0027] Example 3 In vivo experiments confirm that P12 can effectively treat acute lung injury

[0028] 1. Experimental method

[0029] A mouse model of acute lung injury was constructed. Select male, 6-8 week-old SPF grade C57BL6 mice, and weigh them. Give 5% chloral hydrate, inject intraperitoneally at a dose of 6 μl / g for anesthesia, and then fix it on the operating table in the supine position. Under sterile conditions, hold ophthalmic scissors to cut off the neck hair, and 75% medical alcohol cotton balls to disinfect the neck skin three times , the skin of the neck was cut about 0.5 cm in length, and the tissue was peeled off layer by layer with sterile ophthalmic forceps to expose the trachea. A 1ml syringe was selected to absorb sterile LPS (Sigma Company). The control group selected sterile PBS solution and underwent tracheal puncture. One hour before LPS instillation, instill 50 μL of P12 and P13 (1 μM) suspended in PBS. After the injection, the syringe was pulled...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of a polypeptide modified nano particle to preparation of drugs for treating acute lung injury. Proved by in vitro and in vivo experiments for the first time, a gold nano particle modified by CLPFFD can effectively inhibit neutrophile granulocyte migration, has a remarkable anti-inflammatory effect on acute lung injury, and can effectively promote lung injury repair in the middle and later periods of acute lung injury, and therefore the nano particle can be used to prepare the drugs for treating acute lung injury, and has the advantages that the curative effect is remarkable, specific cells can be targeted, in vivo distribution and cell penetrability are better, in vivo tracking is facilitated, and the like. A new way is provided for treating acute lung injury.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to the application of a polypeptide-modified nano particle in the preparation of a drug for treating acute lung injury. Background technique [0002] Acute lung injury (ALI) is the injury of alveolar epithelial cells and capillary endothelial cells caused by various direct (various types of pneumonia, foreign body aspiration, etc.) and indirect injury factors (trauma, infection, shock, etc.), resulting in Diffuse pulmonary interstitial and alveolar edema, resulting in acute hypoxic respiratory insufficiency. The early stage of acute lung injury is characterized by increased permeability of the barrier between pulmonary capillary endothelial cells and alveolar epithelial cells, and a large amount of edema fluid accumulates in the alveoli and pulmonary interstitium, which is rich in protein and mainly composed of neutrophils. A variety of inflammatory cells. Neutrophils adhere t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/08A61K33/24A61K47/52A61K47/64A61P29/00A61P11/00C12Q1/02
CPCA61K38/08G01N33/5029G01N33/5044A61K33/24
Inventor 杨红李强熊叶高炜包爱华傅强
Owner SHANGHAI FIRST PEOPLES HOSPITAL